Kala Bio KALA
NASDAQ KALA
$0.42 -0.01 (-2.37%)
As of: Oct 1, 2026 · 3:59 PM EDT

Kala Bio (KALA) Short term Debt (2016 - 2025)

Updated

Kala Bio (KALA) recorded Short term Debt of $28.41 million in Q3 2025, up 58.0% from $17.98 million a year earlier and up 198.7% from the prior quarter.

Analysis

Kala Bio (KALA) Short term Debt (2016 - 2025) Analysis & Trends

At the end of FY2024, Kala Bio reported Short term Debt of $10.34 million.

  • Across earlier years, Short term Debt came in at $5 million in FY2022.
  • The Q3 2025 figure is the highest quarterly Short term Debt in data going back to Q4 2016.
  • Per Business Quant, the preceding three quarters came in at $9.51 million (Q2 2025), $15.5 million (Q1 2025) and $10.34 million (Q4 2024).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn
10 Kala Bio 6.57 Mn 6.57 Mn -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2025 28.41 Mn
Jun 30, 2025 9.51 Mn
Mar 31, 2025 15.50 Mn
Dec 31, 2024 10.34 Mn
Sep 30, 2024 17.98 Mn
Jun 30, 2024 11.99 Mn
Mar 31, 2024 5.99 Mn
Dec 31, 2022 5.00 Mn
Sep 30, 2018 3.33 Mn
Jun 30, 2018 1.67 Mn
Dec 31, 2017 6.67 Mn
Sep 30, 2017 6.11 Mn
Jun 30, 2017 2.22 Mn
Dec 31, 2016 556,000.00
API Access

Kala Bio Short term Debt API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=short-term-debt&ticker=KALA&period=max&api_key=YOUR_API_KEY